Human Antibody Fragment and Nanoparticles to Inhibit Rabies Virus
Author Information
Author(s): Liu Xinjian, Lin Hong, Tang Qi, Li Chen, Yang Songtao, Wang Zhongcan, Wang Changjun, He Qing, Cao Brian, Feng Zhenqing, Guan Xiaohong, Zhu Jin
Primary Institution: Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing, China
Hypothesis
Can a human antibody fragment and its calcium phosphate nanoparticles effectively inhibit rabies virus infection?
Conclusion
The study found that the human Fab094 antibody and its calcium phosphate nanoparticles are effective candidates for rabies post-exposure prophylaxis.
Supporting Evidence
- The antibody Fab094 showed specific binding to rabies virus glycoprotein.
- Fab094-CPNPs demonstrated higher neutralization activity than Fab094 alone.
- In vivo studies indicated that Fab094 and Fab094-CPNPs provided protection comparable to human rabies immunoglobulin.
- Statistical analysis showed significant differences in survival rates between treatment groups.
Takeaway
Scientists created a special antibody from vaccinated people that can fight the rabies virus, and they made it even better by putting it in tiny particles.
Methodology
The study involved constructing a phage display library from blood lymphocytes of vaccinated volunteers, selecting antibodies that bind to rabies virus, and testing their efficacy in vitro and in vivo.
Potential Biases
Potential bias in the selection of antibody fragments and the specific population used for the study.
Limitations
The study primarily focused on a single antibody fragment and its nanoparticles, which may limit the generalizability of the findings.
Participant Demographics
Participants were 45 healthy volunteers who were immunized with rabies vaccine.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website